Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Corsi

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patientsP F Conte, M V Dieci, G Bisagni, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2023
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" studyAlessandra A Prete, Paolo Manca, Marco Messina, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 27, 2021
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patientsCarolina D Avila-Mesquita, Ariel E S Couto, Ligia C B Campos, et al.
Cytokine|February 1, 2024
Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infectionFabiola Mestriner, Daniely F Francisco, Ligia C B Campos, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patientsP F Conte, M V Dieci, G Bisagni, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2023
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" studyAlessandra A Prete, Paolo Manca, Marco Messina, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 27, 2021
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patientsCarolina D Avila-Mesquita, Ariel E S Couto, Ligia C B Campos, et al.
Cytokine|February 1, 2024
Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infectionFabiola Mestriner, Daniely F Francisco, Ligia C B Campos, et al.
Pageof 14